Maviglin 500 mg 5 MG 60 Caps (Metformin) Metformina, Glibenclamida
It is indicated for non-insulin dependent diabetes mellitus (Type II), no cetoacidósica when dietary measures and monotherapy with sulphonylureas or biguanides are not sufficient to achieve adequate levels of glycemia.
Hypersensitivity to glyburide and metformin, gestational diabetes, insulin dependent diabetes, ketoacidosis, diabetic coma and precoma, serum levels above 12 mg / 1 creatinine; propensity to lactic acidosis: severe alterations in hepatic and renal function, diabetic patients likely to produce impaired renal or hepatic function: severe cardiovascular disease (heart failure, cardiogenic shock, septic shock, impaired peripheral arterial circulation.), alcoholism chronic and pregnancy.
Route of administration: Oral.
Box with 60 tablets 500/5 mg.Box with 30 tablets of 500 / 2.5 mg.